Interferon Human Recombinant D/In Dry (Rekolin)

Human recombinant interferon d/in dry, commercial name "Rekolin", is a drug belonging to the pharmacological group of antiviral interferons. It is produced in Russia by the Vector-Pharm company and is used to treat various diseases.

The international name of this drug is interferon alpha. It is also known by synonyms such as Viferon 1, Viferon 2, Viferon 3, Wellferon, human leukocyte interferon, human recombinant interferon alpha-2, Reaferon, Reaferon-EC.

The dosage form of Recolin is presented in the form of a lyophilized powder for the preparation of an injection solution. Two concentrations are available: 1,000,000 IU and 3,000,000 IU. The main active ingredient is recombinant human interferon alpha.

Recolin is used to treat the following diseases:

1. Hairy cell leukemia
2. Chronic myeloid leukemia
3. Viral hepatitis B
4. Viral active hepatitis C
5. Primary (essential) and secondary thrombocytosis
6. Transitional form of chronic granulocytic leukemia and myelofibrosis
7. Multiple myeloma
8. Kidney cancer
9. AIDS-related Kaposi's sarcoma
10. Mycosis fungoides
11. Reticulosarcoma
12. Multiple sclerosis
13. Prevention and treatment of influenza and acute respiratory viral infection.

However, there are contraindications to the use of Recolin. It is not recommended to use the drug in the following cases:

1. Hypersensitivity to the components of the drug
2. Severe heart disease (including history of acute myocardial infarction)
3. Severe dysfunction of the liver, kidneys or hematopoietic system
4. Epilepsy and/or other disorders of the central nervous system
5. Chronic hepatitis against the background of decompensated cirrhosis of the liver
6. Chronic hepatitis in patients receiving or recently receiving immunosuppressive drugs (except for short-term pre-treatment with steroids).

Restrictions should also be observed when using Recolin during pregnancy, breastfeeding and in children.

When using Recolin, side effects are possible, including lethargy, weakness, headache, fever, muscle and joint pain, nausea, vomiting, diarrhea, excessive sweating, anorexia, allergic reactions and changes in laboratory parameters (for example, changes in liver function). If you experience any side effects while using Recolin, it is important to contact your doctor.

The drug Rekolin is usually used as prescribed by a doctor and under his supervision. The dosage and regimen may vary depending on the specific disease. Recolin can be administered intramuscularly, subcutaneously or intravenously.

It is important to consult your doctor or pharmacist for more detailed information about using Recolin, especially based on your individual health conditions.

The information provided is based on current knowledge and is subject to change. Always follow the instructions provided with the drug and consult a healthcare professional or pharmacist before starting treatment with a new drug.